-
Mashup Score: 1Infection Control Today Exclusive: Understanding Multisystem Inflammatory Syndrome in Children (MIS-C) in Relation to COVID-19 - 7 month(s) ago
Fibi Attia, MD, MP, CIC, and her colleagues conducted a study on multisystem inflammatory syndrome in children (MIS-C) linked to COVID-19. The study focused on the characteristics, implications, and outcomes of MIS-C cases, particularly cardiac dysfunction. The interview discusses the study’s goals and key findings, stressing the importance of detecting MIS-C cases and the need for more research on COVID-19 vaccines.
Source: www.infectioncontroltoday.comCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Infection Control Today Exclusive: Understanding Multisystem Inflammatory Syndrome in Children (MIS-C) in Relation to COVID-19 - 7 month(s) ago
Fibi Attia, MD, MP, CIC, and her colleagues conducted a study on multisystem inflammatory syndrome in children (MIS-C) linked to COVID-19. The study focused on the characteristics, implications, and outcomes of MIS-C cases, particularly cardiac dysfunction. The interview discusses the study’s goals and key findings, stressing the importance of detecting MIS-C cases and the need for more research on COVID-19 vaccines.
Source: www.infectioncontroltoday.comCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Infection Control Today Exclusive: Understanding Multisystem Inflammatory Syndrome in Children (MIS-C) in Relation to COVID-19 - 7 month(s) ago
Fibi Attia, MD, MP, CIC, and her colleagues conducted a study on multisystem inflammatory syndrome in children (MIS-C) linked to COVID-19. The study focused on the characteristics, implications, and outcomes of MIS-C cases, particularly cardiac dysfunction. The interview discusses the study’s goals and key findings, stressing the importance of detecting MIS-C cases and the need for more research on COVID-19 vaccines.
Source: www.infectioncontroltoday.comCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 4Multisystem inflammatory syndrome in children — what parents need to know - Harvard Health - 10 month(s) ago
Multisystem inflammatory syndrome, or MIS-C, is a rare syndrome in some children that affects the heart and other organs. It may be a reaction to a current or past COVID-19 infection, but test resu…
Source: Harvard HealthCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Pediatric cancer patients who develop MIS-C after COVID-19 have a worse clinical course than patients without MIS-C, a study suggests.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3The Lancet Rheumatology Home Page - 1 year(s) ago
Explore clinical research, expert reviews, and comment and opinion from The Lancet Rheumatology. A voice for rheumatology specialists worldwide
Source: www.thelancet.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study - 1 year(s) ago
Recovery rates, including occurrence and resolution of coronary artery aneurysms, were similar for primary treatment with intravenous immunoglobulin when compared to glucocorticoids or intravenous immunoglobulin plus glucocorticoids. Initial treatment with glucocorticoids appears to be a safe alternative to immunoglobulin or combined therapy, and might be advantageous in view of the cost and…
Source: The Lancet RheumatologyCategories: Latest Headlines, RheumatologyTweet-
NEW RESEARCH from the @BATStudy—Initial treatment for #MISC with glucocorticoids is associated with similar outcomes to treatment with intravenous immunoglobulin or combined therapy, including resolution of coronary artery aneurysms https://t.co/saefomBDFU #PIMS-TS #OpenAccess https://t.co/AEa4D8a1Y5
-
-
Mashup Score: 0
In this RCT, treatment with methylprednisolone in children with PIMS-TS did not significantly affect the length of hospital stay compared with intravenous immunoglobulins. Intravenous methylprednisolone could be an acceptable first-line treatment in children with PIMS-TS.
Categories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 6Experts update definition of MIS-C - 1 year(s) ago
The new definition aims to better distinguish between MIS-C and other inflammatory conditions.
Source: American Academy of PediatricsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 5NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical journals - 2 year(s) ago
NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary
Source: www.jwatch.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
The interview discusses the MIS-C study's goals and findings, stressing the importance of detecting MIS-C cases. https://t.co/fEx0y45pBC #MISC #COVID